Works matching IS 17762596 AND DT 2021 AND VI 16 AND IP 6

Results: 16

Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC.

Published in:

2021

By:

Lamb, Yvette N.

Publication type:

Correction Notice

Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy.

Published in:

Targeted Oncology, 2021, v. 16, n. 6, p. 813, doi. 10.1007/s11523-021-00852-z

By:

Sheng, Iris Y.;
Gupta, Shilpa;
Reddy, Chandana A.;
Angelini, Dana;
Funchain, Pauline;
Sussman, Tamara A.;
Sleiman, Joseph;
Ornstein, Moshe C.;
McCrae, Keith;
Khorana, Alok A.

Publication type:

Article

Acknowledgement to Referees.

Published in:: Targeted Oncology, 2021, v. 16, n. 6, p. 697, doi. 10.1007/s11523-021-00851-0
Publication type:: Article

Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).

Published in:

Targeted Oncology, 2021, v. 16, n. 6, p. 789, doi. 10.1007/s11523-021-00850-1

By:

Aglietta, Massimo;
Chiarion-Sileni, Vanna;
Fava, Paolo;
Guidoboni, Massimo;
Depenni, Roberta;
Minisini, Alessandro;
Consoli, Francesca;
Ascierto, Paolo;
Rinaldi, Gaetana;
Banzi, Maria;
Marconcini, Riccardo;
Gueli, Rossana;
Ferraresi, Virginia;
Tucci, Marco;
Tonini, Giuseppe;
Lo Re, Giovanni;
Guida, Michele;
Del Vecchio, Michele;
Marcon, Ilaria Gioia;
Queirolo, Paola

Publication type:

Article

Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study.

Published in:

Targeted Oncology, 2021, v. 16, n. 6, p. 761, doi. 10.1007/s11523-021-00849-8

By:

Hawkes, Eliza A.;
Phillips, Tycel;
Budde, Lihua Elizabeth;
Santoro, Armando;
Saba, Nakhle S.;
Roncolato, Fernando;
Gregory, Gareth P.;
Verhoef, Gregor;
Offner, Fritz;
Quero, Cristina;
Radford, John;
Giannopoulos, Krzysztof;
Stevens, Don;
Thall, Aron;
Huang, Bo;
Laird, A. Douglas;
Sandner, Robin;
Ansell, Stephen M.

Publication type:

Article

A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes.

Published in:

Targeted Oncology, 2021, v. 16, n. 6, p. 801, doi. 10.1007/s11523-021-00848-9

By:

Chouaid, Christos;
Filleron, Thomas;
Debieuvre, Didier;
Pérol, Maurice;
Girard, Nicolas;
Dansin, Eric;
Lena, Hervé;
Gervais, Radj;
Cousin, Sophie;
Otto, Josiane;
Schott, Roland;
Planchard, David;
Madroszyk, Anne;
Kaderbhai, Courèche;
DUBRAY-Longeras, Pascale;
Hiret, Sandrine;
Pichon, Eric;
Clément-Duchêne, Christelle;
Chenuc, Gaëlle;
Simon, Gaëtane

Publication type:

Article

Correction to: Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice.

Published in:

2021

By:

Brufsky, Adam;
Liu, Xianchen;
Li, Benjamin;
McRoy, Lynn;
Layman, Rachel M.

Publication type:

Correction Notice

Correction to: Isatuximab: A Review of Its Use in Multiple Myeloma.

Published in:

2021

By:

Frampton, James E.

Publication type:

Correction Notice

Phase II Study of Third-Line Panitumumab Rechallenge in Patients with Metastatic Wild-Type KRAS Colorectal Cancer Who Obtained Clinical Benefit from First-Line Panitumumab-Based Chemotherapy: JACCRO CC-09.

Published in:

Targeted Oncology, 2021, v. 16, n. 6, p. 753, doi. 10.1007/s11523-021-00845-y

By:

Tsuji, Akihito;
Nakamura, Masato;
Watanabe, Takanori;
Manaka, Dai;
Matsuoka, Hiroshi;
Kataoka, Masato;
Takeuchi, Masahiro;
Ichikawa, Wataru;
Fujii, Masashi

Publication type:

Article

Immune Checkpoint Inhibitors for Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-Analysis.

Published in:

Targeted Oncology, 2021, v. 16, n. 6, p. 743, doi. 10.1007/s11523-021-00844-z

By:

Mehta, Neil K.;
Li, Andraia R.;
Nguyen, Shaun A.;
Kaczmar, John M.;
Neskey, David M.;
Day, Terry A.

Publication type:

Article

Durvalumab: A Review in Extensive-Stage SCLC.

Published in:

Targeted Oncology, 2021, v. 16, n. 6, p. 857, doi. 10.1007/s11523-021-00843-0

By:

Al-Salama, Zaina T.

Publication type:

Article

Olaparib: A Review as First-Line Maintenance Therapy in Advanced Ovarian Cancer.

Published in:

Targeted Oncology, 2021, v. 16, n. 6, p. 847, doi. 10.1007/s11523-021-00842-1

By:

Paik, Julia

Publication type:

Article

Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer.

Published in:

Targeted Oncology, 2021, v. 16, n. 6, p. 839, doi. 10.1007/s11523-021-00841-2

By:

Lee, Arnold

Publication type:

Article

An Overview of the Treatment Efficacy and Side Effect Profile of Pharmacological Therapies in Asian Patients with Breast Cancer.

Published in:

Targeted Oncology, 2021, v. 16, n. 6, p. 701, doi. 10.1007/s11523-021-00838-x

By:

Lu, Yen-Shen;
Yeo, Winnie;
Yap, Yoon-Sim;
Park, Yeon Hee;
Tamura, Kenji;
Li, Huiping;
Cheng, Rebecca

Publication type:

Article

Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration.

Published in:

Targeted Oncology, 2021, v. 16, n. 6, p. 773, doi. 10.1007/s11523-021-00833-2

By:

Hu-Lieskovan, Siwen;
Braiteh, Fadi;
Grilley-Olson, Juneko E.;
Wang, Xiao;
Forgie, Alison;
Bonato, Vinicius;
Jacobs, Ira A.;
Chou, Jeffrey;
Johnson, Melissa L.

Publication type:

Article

Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools.

Published in:

Targeted Oncology, 2021, v. 16, n. 6, p. 823, doi. 10.1007/s11523-021-00831-4

By:

Castagnetti, Fausto;
Binotto, Gianni;
Capodanno, Isabella;
Billio, Atto;
Calistri, Elisabetta;
Cavazzini, Francesco;
Crugnola, Monica;
Gozzini, Antonella;
Gugliotta, Gabriele;
Krampera, Mauro;
Lucchesi, Alessandro;
Merli, Anna;
Miggiano, Maria Cristina;
Minotto, Claudia;
Poggiaspalla, Monica;
Salvucci, Marzia;
Scappini, Barbara;
Tiribelli, Mario;
Trabacchi, Elena;
Rosti, Gianantonio

Publication type:

Article